Disappearance of bulky diffuse large B-cell lymphoma after methotrexate/infliximab withdrawal Hiroyuki TakamatsuTakeshi Yoroidaka Images in Hematology 23 November 2021 Pages: 1 - 2
Hairy kidney in high-grade B-cell lymphoma Verónica Roldán GaliachoJavier Arzuaga-MéndezJuan Carlos García-Ruiz Images in Hematology 09 November 2021 Pages: 3 - 4
Armor sign on PET–CT in a young male with non-Hodgkin’s lymphoma Chen-lu YangXin-rong XiangYu Wu Images in Hematology 11 November 2021 Pages: 5 - 6
Limited increase in antibody titers following mRNA SARS-CoV-2 vaccination for more than 3 years after final dose of anti-CD20 antibody Yohei FunakoshiKimikazu YakushijinHironobu Minami Rapid Communication 04 January 2022 Pages: 7 - 10
Measurement of coagulation factor antibody levels is useful for diagnosis and determining therapeutic efficacy in hemorrhagic patients with autoantibodies to coagulation factor VIII and factor V: results from a single center in Japan Masahiro IekoKazumasa OhmuraAkitada Ichinose Original Article 02 September 2021 Pages: 11 - 20
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance Wenmin HanFeng ZhouXuzhang Lu Original Article 27 August 2021 Pages: 21 - 32
Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial Hirohisa NakamaeMasahide YamamotoHirohiko Shibayama Original Article 11 September 2021 Pages: 33 - 42
All-trans retinoic acid induces differentiation in primary acute myeloid leukemia blasts carrying an inversion of chromosome 16 Vilma DembitzHrvoje LalicDora Visnjic Original Article 21 September 2021 Pages: 43 - 53
Ability of final PET/CT to predict response to first-line treatment in real patients with classical Hodgkin lymphoma Laura Galvez-CarvajalCristina QueroAntonio Rueda Original Article 21 September 2021 Pages: 54 - 60
Implementation of a hospital-at-home (HAH) unit for hematological patients during the COVID-19 pandemic: safety and feasibility Ignacio Gómez-CenturiónGillen OarbeascoaMi Kwon Original Article 22 September 2021 Pages: 61 - 68
A case series of patients treated with inotuzumab ozogamicin for acute lymphoblastic leukemia relapsed after allogeneic hematopoietic cell transplantation Akihiko IzumiTakayoshi TachibanaHideaki Nakajima Original Article 06 September 2021 Pages: 69 - 76
A phase II study of post-transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA-matched related/unrelated allogeneic hematopoietic stem cell transplantation Hirohisa NakamaeTakahiko NakaneMasayuki Hino Original Article 29 September 2021 Pages: 77 - 86
Relationship between serum zinc level and sepsis-induced coagulopathy Yuhei IrieKota HoshinoHiroyasu Ishikura Original Article 20 October 2021 Pages: 87 - 95
Incidence of refractory cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation Fumiaki JinnouchiYasuo MoriKatsuto Takenaka Original Article 15 October 2021 Pages: 96 - 106
Red blood cell exchange in children with sickle cell disease Narcisse ElengaVincent VantilckeThierry Basset Original Article 22 September 2021 Pages: 107 - 113
Favorable prognosis of vaccine-associated immune thrombocytopenia in children is correlated with young age at vaccination: Retrospective survey of a nationwide disease registry Junichi KitazawaHisaya NakadatePlatelet Committee of the Japanese Society of Pediatric Hematology/Oncology Original Article 09 October 2021 Pages: 114 - 122
Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan Akira HayakawaIori SatoShinichiro Okamoto Original Article 03 October 2021 Pages: 123 - 128
Successful rituximab treatment of an elderly Japanese patient with HHV8-positive, HIV-negative multicentric Castleman disease Hajime KagaHonami KurahashiNaoto Takahashi Case Report 30 September 2021 Pages: 129 - 134
Response to blinatumomab or inotuzumab ozogamicin for isolated extramedullary relapse of adult acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantation: a case study Seung-Hwan LeeJae-Ho YoonSeok Lee Case Report 06 October 2021 Pages: 135 - 139
Successful treatment of hepatosplenic T-cell lymphoma with fludarabine, high-dose cytarabine and subsequent unrelated umbilical cord blood transplantation Takaya HondaMasayoshi YamaokaMasaharu Akiyama Case Report 30 September 2021 Pages: 140 - 145
Correction to: A phase II study of post‑transplant cyclophosphamide combined with tacrolimus for GVHD prophylaxis after HLA‑matched related/unrelated allogeneic hematopoietic stem cell transplantation Hirohisa NakamaeTakahiko NakaneMasayuki Hino Correction 01 November 2021 Pages: 146 - 146
Correction to: Irradiation induces homing of donor endothelial progenitor cells in allogeneic hematopoietic stem cell transplantation Lingyu ZengShuang DingKailin Xu Correction 29 November 2021 Pages: 147 - 148